Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fellows’ Forum Case Report: Necrotizing Autoimmune Myopathy

Shivani Garg, MD, Suzana Alex John, MD, & Frehiywot Ayele, MD  |  Issue: December 2017  |  December 18, 2017

This acid phosphatase stain of Patient 2’s muscle biopsy shows large numbers of necrotic fibers (highlighted in the center of the image).

Figure 2B: This acid phosphatase stain of Patient 2’s muscle biopsy shows large numbers of necrotic fibers (highlighted in the center of the image).

Because our patient was in respiratory distress, we evaluated him for cardiac dysfunction and respiratory involvement. Transthoracic echocardiography showed 40% ejection fraction with mild to moderate left ventricular systolic and diastolic dysfunction. His chest CT demonstrated no evidence of interstitial lung disease (ILD), and his NIF measured <-15, highlighting significant respiratory muscle involvement. His arterial blood gas revealed hypoxic hypercapnic respiratory failure, and we intubated him after he failed a bilevel positive airway pressure (BiPAP) trial.

We started the patient on a combination of high-dose steroids and IVIG, because he had severe muscle weakness with profound respiratory muscle involvement leading to respiratory failure. During hospitalization, his weakness improved and his CPK levels trended down to 800 U/L. We continued him on steroids and monthly IVIG. On his follow-up visit two months later, his respiratory status and muscle strength had significantly improved.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Triggered by Statins?

Unlike other statin-associated myopathies, HMGCR Ab-related IMNM features a complex pathogenesis characterized by extensive myocyte necrosis with scarce phlogistic infiltration in biopsy and the presence of HMGCR antibodies.8,9 The recently discovered HMGCR Ab is composed of 200 kDa and 100 kDa proteins with specificity for the carboxy terminus of the HMGCR enzyme.10 Based on immunoprecipitation assays, these antibodies may be a causal link between statin exposure and IMNM.10 A study by Mammen et al reports the prevalence of these HMGCR antibodies in all patients suspected of inflammatory myopathy to be around 6%, making it the second most common myositis-specific antibody after the anti-Jo1 antibody.11

The proposed pathogenesis of statins is through upregulation of the expression of MHC1 and the HMGCR enzyme in regenerating muscle fibers.2,7,12 Overexpression of MHC1 may result from endoplasmic reticulum stress induced by HMGCR inhibition, leading to depletion of metabolic intermediates.12,13 Endoplasmic reticulum stress leads to activation of the NF-kB pathway, which in turn activates the cytokine and chemokine production involved in immune processes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Muscle Attack

After the initial trigger of the autoimmune process, researchers hypothesize muscle damage is sustained by overexpression of HMGCR in regenerating muscle even after statins are discontinued.11,14 This supposition is supported by the discovery of upregulated HMCGR expression in cells expressing neural cell adhesion molecules (NCAM) in regenerating muscle fibers.11 This explains the progressive weakness found in these patients even after statin discontinuation.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Other Rheumatic ConditionsResearch Rheum Tagged with:Autoimmunecase reportClinicalDiagnosisfellowFellowsFellows ForumHMGCR Ab-related IMNMimmune-mediated necrotizing myopathyinflammatory myopathymorbiditymortalitymuscle weaknessmyalgianecrotizingpatient careResearchrespiratoryrheumatologistrheumatologyStatinstatin-associated myopathy

Related Articles
    Valentyn Volkov / shutterstock.com

    Did Shiitake Mushrooms Induce Immune-Mediated Necrotizing Myopathy?

    April 15, 2019

    Idiopathic inflammatory myopathies are heterogenous, acquired immune-mediated muscle diseases. Over the past decade, immune-mediated necrotizing myopathy has been recognized as a subcategory of idiopathic inflammatory myopathy characterized by myofiber necrosis in the absence of prominent inflammatory cells.1 Autoantibodies against signal recognition particle (SRP) and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) are thought to be associated with the…

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Drug Updates

    January 1, 2009

    Information on safety, labeling changes, and pharmaceutical research

    Managing Myositis in 3 Different Scenarios

    February 18, 2018

    SAN DIEGO—In Hot Topics in Myositis, a session held Nov. 7 at the 2017 ACR/ARHP Annual Meeting, rheumatologists discussed treating myositis patients in three different clinical scenarios: persistently elevated creatine kinase (CK), immune-mediated necrotizing myopathies and lung disease. Elevated CK Patients with persistently elevated levels of CK enzyme and normal muscle strength “may still have…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences